These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19856724)

  • 1. The potential of blood group genotyping for transfusion medicine practice.
    Westhoff CM
    Immunohematology; 2008; 24(4):190-5. PubMed ID: 19856724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services.
    Hillyer CD; Shaz BH; Winkler AM; Reid M
    Transfus Med Rev; 2008 Apr; 22(2):117-32. PubMed ID: 18353252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular testing for transfusion medicine.
    Westhoff CM
    Curr Opin Hematol; 2006 Nov; 13(6):471-5. PubMed ID: 17053461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature.
    Akinbolaji TJ
    Immunohematology; 2024 Jun; 40(2):58-64. PubMed ID: 38910442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help?
    El Kenz H; Efira A; Le PQ; Thiry C; Valsamis J; Azerad MA; Corazza F
    Transl Res; 2014 Jan; 163(1):36-42. PubMed ID: 24120494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale blood group genotyping: clinical implications.
    Avent ND
    Br J Haematol; 2009 Jan; 144(1):3-13. PubMed ID: 19016734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
    Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood group genotyping: from patient to high-throughput donor screening.
    Veldhuisen B; van der Schoot CE; de Haas M
    Vox Sang; 2009 Oct; 97(3):198-206. PubMed ID: 19548962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations of red blood cell molecular testing in transfusion medicine.
    Svensson AM; Delaney M
    Expert Rev Mol Diagn; 2015; 15(11):1455-64. PubMed ID: 26367503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technologies to replace current blood typing reagents.
    Storry JR
    Curr Opin Hematol; 2007 Nov; 14(6):677-81. PubMed ID: 17898574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-based assays for patient testing: their application, interpretation, and correlation of results.
    Lomas-Francis C; DePalma H
    Immunohematology; 2008; 24(4):180-90. PubMed ID: 19856723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion therapy for autoimmune hemolytic anemia patients: a laboratory perspective.
    Drouillard DD
    Clin Lab Sci; 2008; 21(1):7-11. PubMed ID: 18335854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular approaches to transfusion medicine in Polynesians and Maori in New Zealand.
    Edinur HA; Dunn PP; Lea RA; Chambers GK
    Int J Immunogenet; 2013 Dec; 40(6):460-70. PubMed ID: 23870060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of DNA-based assays for donor screening and regulatory issues.
    Strauss D; Reid ME
    Immunohematology; 2008; 24(4):175-9. PubMed ID: 19856722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of DNA testing for red cell antigens in blood centres.
    Jungbauer C
    Transfus Apher Sci; 2011 Aug; 45(1):61-8. PubMed ID: 21741314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible automated platform for blood group genotyping on DNA microarrays.
    Paris S; Rigal D; Barlet V; Verdier M; Coudurier N; Bailly P; Brès JC
    J Mol Diagn; 2014 May; 16(3):335-42. PubMed ID: 24726279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEA BeadChip™ technology in immunohematology.
    Paccapelo C; Truglio F; Antonietta Villa M; Revelli N; Marconi M
    Immunohematology; 2015; 31(2):81-90. PubMed ID: 26495894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell typing the sensitized transfusion-dependent patient.
    Rios M; Hue-Roye K; Storry JR; Reiss RF
    Ann Clin Lab Sci; 2000 Oct; 30(4):379-86. PubMed ID: 11045761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.